Courthouse News Service

No Injunction Against Test for Genetic Defects

SAN FRANCISCO (CN) - A biotech company cannot block its competitor from using a prenatal test for genetic defects, a federal judge ruled, noting that an injunction would put the competitor out of ...
Business Wire

Affymetrix and Ariosa Diagnostics Announce Signing of Multi-Year Supply Agreement in Support of Ariosa’s Non-Invasive Prenatal Test

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
TASS

Microarray technology proves superior to sequencing for non-invasive prenatal testing

Ariosa Diagnostics announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony Non-Invasive Prenatal Test SAN JOSE, California, ...
TASS

Harmony Prenatal Test to be superior to conventional pregnancy screening for Down syndrome

New England Journal of Medicine publishes findings of largest non-invasive prenatal testing study involving more than 18,500 expectant mothers SAN JOSE, California, April 2 /PRNewswire/ -- Roche (SIX: ...